Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Viral Gastroenteritis Market Report 2024

Viral Gastroenteritis Global Market Report 2025 – By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

Viral Gastroenteritis Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Viral Gastroenteritis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Viral Gastroenteritis Market Definition

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

The main types of drugs in viral gastroenteritis are antibiotics, antacids, laxatives, antimotility agents, and others. Antacids refer to medicines that neutralize the acid in the stomach to relieve heartburn and indigestion. The various diagnosis includes a physical examination and a rapid stool test that is indicated by various indications such as watery diarrhea, abdominal cramps, pain, and others. The various types of viruses include norovirus, rotavirus, astrovirus, and enteric adenovirus. These are used by various end-users such as hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers, and others.

Viral Gastroenteritis Market Segmentation

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

4) By Antimotility Agents: Loperamide, Diphenoxylate

5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Viral Gastroenteritis Market Size and growth rate 2025 to 2029: Graph

Viral Gastroenteritis Market Size 2025 And Growth Rate

The viral gastroenteritis market size has grown steadily in recent years. It will grow from $6.75 billion in 2024 to $7.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to the prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, and climate and environmental factors

Viral Gastroenteritis Market Growth Forecast

The viral gastroenteritis market size is expected to see strong growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to global health preparedness, climate change impact, one health approach, epidemiological surveillance systems, education and public awareness. Major trends in the forecast period include vaccine development, advanced diagnostics, telemedicine in diagnosis, collaborative research initiatives, personalized medicine approaches, and digital health solutions.

Book your 30 minutes free consultation with our research experts

Contact Us

Viral Gastroenteritis Market Driver: Rising Prevalence Of Gastrointestinal Disorders To Drive Market Growth

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the viral gastroenteritis market going forward. Gastrointestinal (GI) disorders refer to a disease that occurs within or on any part of the gastrointestinal tract. Viral gastroenteritis drugs and diagnosis treatments help people suffering from the illness with proper and appropriate medication. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the viral gastroenteritis market.

Viral Gastroenteritis Market Driver: Rising Emphasis On Hygiene And Sanitation To Drive Market Growth

The increasing awareness about hygiene and sanitation is expected to propel the growth of viral gastroenteritis market going forward. Hygiene encompasses personal behaviors like handwashing, waste disposal, and personal cleanliness to maintain a clean environment. Sanitation involves providing facilities for safe waste disposal, and water treatment, and ensuring a hygienic environment in homes, communities, and public spaces. Hygiene and sanitation are critical in preventing the transmission of viruses causing gastroenteritis. These measures help interrupt the fecal-oral route of transmission, reduce contamination, and contribute to overall community health by minimizing the risk and impact of viral gastroenteritis outbreaks. For instance, in March 2024, according to the World Health Organization (WHO), a Switzerland-based United Nations agency, a total of 57% of the global population, equivalent to 4.6 billion people, utilized safely managed sanitation services in 2022, with 33% (2.7 billion) accessing private facilities linked to treated sewers, 21% (1.7 billion) using toilets or latrines that safely disposed of waste in situ, and 88% of the overall population (7.2 billion) relying on at least basic sanitation services. Therefore, the increasing awareness about hygiene and sanitation is driving the growth of the viral gastroenteritis market.

Global Viral Gastroenteritis Market Major Players

Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

Global Viral Gastroenteritis Market Trend: Product Innovations Transforming The Viral Gastroenteritis Market

Product innovation is the key trend gaining popularity in the viral gastroenteritis market. Major companies operating in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX to prevent rotavirus gastroenteritis in infants. This new presentation formulation becomes more convenient for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use. The approval is supported by international clinical trial data demonstrating safety and tolerability compared to the lyophilized formulation and non-inferiority of immunogenicity.

Global Viral Gastroenteritis Market Trend: Innovative PCR Kits Reshaping The Viral Gastroenteritis Market

Major companies operating in the viral gastroenteritis market are developing new products such as PCR kits for gastrointestinal infectious diseases to gain a competitive edge in the market. PCR kits, or Polymerase Chain Reaction kits, are molecular biology tools designed for the amplification and detection of specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based molecular diagnostic solutions company, launched 10 Real-Time PCR Kits designed for accurate detection of gastrointestinal pathogens, forming a comprehensive Total PCR Solution when integrated with their extraction solution and PCR system. The Real-Time PCR Kits cover a range of bacterial, viral, and parasitic pathogens associated with gastrointestinal infections. These include diseases caused by various bacterial pathogens such as Campylobacter, Salmonella, Shigella, and Clostridioides difficile, as well as viral agents like Adenovirus, Rotavirus, Astrovirus, and Norovirus. This innovative solution provides a streamlined approach from sample pre-processing to PCR amplification analysis.

Viral Gastroenteritis Market Merger And Acquisition: Hillevax And Kanghua Collaborate On Development Of Next-Generation Norovirus Vaccine

In January 2024, HilleVax Inc., a Switzerland-based biotech company, collaborated with Chengdu Kanghua Biological Products Co. Ltd. Through this collaboration, HilleVax Inc. aims to develop HIL-216, a next-generation norovirus vaccine that targets six common genotypes, with clinical trials set to begin in 2024 following FDA clearance. Kanghua Biological Products Co. Ltd. is a China-based firm focused on developing and manufacturing biological products and vaccines for veterinary and human health.

Regional Outlook For The Global Viral Gastroenteritis Market

North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral gastroenteritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Gastroenteritis Market?

The viral gastroenteritis market consists of revenues earned by entities by providing various diagnostics such as polymerase chain reaction testing and immunoassays. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral gastroenteritis market also includes sales of antiemetics, and chemotherapy drugs used for treating viral gastroenteritis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Viral Gastroenteritis Industry?

The viral gastroenteritis market research report is one of a series of new reports from The Business Research Company that provides viral gastroenteritis market statistics, including viral gastroenteritis industry global market size, regional shares, competitors with a viral gastroenteritis market share, detailed viral gastroenteritis market segments, market trends, and opportunities, and any further data you may need to thrive in the viral gastroenteritis industry. This viral gastroenteritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Viral Gastroenteritis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $7.08 billion
Revenue Forecast In 2034 $8.73 billion
Growth Rate CAGR of 5.4% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users Subsegments: 1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Viral Gastroenteritis Market Characteristics

    3. Viral Gastroenteritis Market Trends And Strategies

    4. Viral Gastroenteritis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Viral Gastroenteritis Growth Analysis And Strategic Analysis Framework

    5.1. Global Viral Gastroenteritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Viral Gastroenteritis Market Growth Rate Analysis

    5.4. Global Viral Gastroenteritis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Viral Gastroenteritis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Viral Gastroenteritis Total Addressable Market (TAM)

    6. Viral Gastroenteritis Market Segmentation

    6.1. Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antibiotics

    Antacids

    Laxatives

    Antimotility Agents

    Others Drugs

    6.2. Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Physical Examination

    Rapid Stool Test

    6.3. Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Watery Diarrhea

    Abdominal Cramps

    Pain

    Other Indications

    6.4. Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Norovirus

    Rotavirus

    Astrovirus

    Enteric Adenovirus

    6.5. Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Pharmaceutical Companies

    Diagnostic Centers

    Ambulatory Care Centers

    Others End Users

    6.6. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Broad-Spectrum Antibiotics

    Narrow-Spectrum Antibiotics

    Penicillins

    Macrolides

    Cephalosporins

    6.7. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Proton Pump Inhibitors (PPIs)

    Histamine-2 Receptor Antagonists (H2 Blockers)

    Magnesium-Based Antacids

    Calcium-Based Antacids

    Sodium Bicarbonate

    6.8. Global Viral Gastroenteritis Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Bulk-Forming Laxatives

    Osmotic Laxatives

    Stimulant Laxatives

    Stool Softeners

    6.9. Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Loperamide

    Diphenoxylate

    6.10. Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral Rehydration Salts (Ors)

    Zinc Supplements

    Antiemetics

    7. Viral Gastroenteritis Market Regional And Country Analysis

    7.1. Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Viral Gastroenteritis Market

    8.1. Asia-Pacific Viral Gastroenteritis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Viral Gastroenteritis Market

    9.1. China Viral Gastroenteritis Market Overview

    9.2. China Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Viral Gastroenteritis Market

    10.1. India Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Viral Gastroenteritis Market

    11.1. Japan Viral Gastroenteritis Market Overview

    11.2. Japan Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Viral Gastroenteritis Market

    12.1. Australia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Viral Gastroenteritis Market

    13.1. Indonesia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Viral Gastroenteritis Market

    14.1. South Korea Viral Gastroenteritis Market Overview

    14.2. South Korea Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Viral Gastroenteritis Market

    15.1. Western Europe Viral Gastroenteritis Market Overview

    15.2. Western Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Viral Gastroenteritis Market

    16.1. UK Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Viral Gastroenteritis Market

    17.1. Germany Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Viral Gastroenteritis Market

    18.1. France Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Viral Gastroenteritis Market

    19.1. Italy Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Viral Gastroenteritis Market

    20.1. Spain Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Viral Gastroenteritis Market

    21.1. Eastern Europe Viral Gastroenteritis Market Overview

    21.2. Eastern Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Viral Gastroenteritis Market

    22.1. Russia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Viral Gastroenteritis Market

    23.1. North America Viral Gastroenteritis Market Overview

    23.2. North America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Viral Gastroenteritis Market

    24.1. USA Viral Gastroenteritis Market Overview

    24.2. USA Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Viral Gastroenteritis Market

    25.1. Canada Viral Gastroenteritis Market Overview

    25.2. Canada Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Viral Gastroenteritis Market

    26.1. South America Viral Gastroenteritis Market Overview

    26.2. South America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Viral Gastroenteritis Market

    27.1. Brazil Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Viral Gastroenteritis Market

    28.1. Middle East Viral Gastroenteritis Market Overview

    28.2. Middle East Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Viral Gastroenteritis Market

    29.1. Africa Viral Gastroenteritis Market Overview

    29.2. Africa Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Viral Gastroenteritis Market Competitive Landscape And Company Profiles

    30.1. Viral Gastroenteritis Market Competitive Landscape

    30.2. Viral Gastroenteritis Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

    31. Viral Gastroenteritis Market Other Major And Innovative Companies

    31.1. Takeda Pharmaceutical Company Limited

    31.2. C.H. Boehringer Sohn AG & Co. KG

    31.3. Mylan N.V.

    31.4. Astellas Pharma Inc.

    31.5. Fresenius Kabi AG

    31.6. Bausch Health Companies Inc.

    31.7. Alexion Pharmaceuticals Inc.

    31.8. Horizon Therapeutics Plc

    31.9. Dr. Reddy’s Laboratories Ltd.

    31.10. BioMarin Pharmaceutical Inc.

    31.11. Lupin Limited

    31.12. Zydus Lifesciences Limited

    31.13. Alkem Laboratories Ltd

    31.14. Ironwood Pharmaceuticals Inc

    31.15. ANI Pharmaceuticals Inc.

    32. Global Viral Gastroenteritis Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Viral Gastroenteritis Market

    34. Recent Developments In The Viral Gastroenteritis Market

    35. Viral Gastroenteritis Market High Potential Countries, Segments and Strategies

    35.1 Viral Gastroenteritis Market In 2029 - Countries Offering Most New Opportunities

    35.2 Viral Gastroenteritis Market In 2029 - Segments Offering Most New Opportunities

    35.3 Viral Gastroenteritis Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Viral Gastroenteritis Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Abbvie Inc. Financial Performance
  • Table 83: Sanofi S.A. Financial Performance
  • Table 84: Abbott Laboratories Financial Performance
  • Table 85: GlaxoSmithKline Plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Viral Gastroenteritis Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Viral Gastroenteritis Market, Sub-Segmentation Of Antimotility Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Viral Gastroenteritis Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Abbvie Inc. Financial Performance
  • Figure 83: Sanofi S.A. Financial Performance
  • Figure 84: Abbott Laboratories Financial Performance
  • Figure 85: GlaxoSmithKline Plc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Forklift Truck Global Market Report 2025 – By Product Type (Counterbalance, Warehouse), By Technology (Electric Power, Internal Combustion Engine), By Class (Class I, Class II, Class III, Class IV, Class V), By End-User (Retail and Wholesale, Logistics, Automotive, Food Industry, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Sale Terminals Global Market Report 2025 – By Product (Mobile, Fixed), By Component (Hardware, Software, Service), By Technology (Biometric, Traditional), By Operating System (Windows, Linux, MAC), By Application  (Restaurants, Hospitality, Healthcare, Retail, Warehouse, Entertainment, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Warehouse Execution System Global Market Report 2025 – By Component (Software, Service), By Deployment (On-Premises, Cloud), By End User (Consumer Electronics, Healthcare, Food And Beverages, Automotive, Third-Party Logistics (3PL), Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart And Mobile Supply Chain Solutions Global Market Report 2025 – By Solution (Transportation Management Systems (TMS), Warehouse Management Systems (WMS), Sourcing and Procurement, Supply Chain Planning (SCP), Manufacturing Execution Systems (MES)), By Enterprise Size (Small and Medium Enterprises, Large Enterprises), By End-User (Retail and Consumer Goods, IT and Telecom, Manufacturing, BFSI, Government, Energy and Utilities, Healthcare, Transportation and Logistics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Warehousing And Storage Global Market Report 2025 – By Type (General Warehousing And Storage, Refrigerated Warehousing And Storage, Specialized Warehousing And Storage, Farm Product Warehousing And Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses, Cooperative Warehouses), By End-Use (Retail Industry, Manufacturing Industry, Consumer Goods Industry, Food And Beverages Industry, Healthcare Industry, E-Commerce, Other End Use) – Market Size, Trends, And Global Forecast 2025-2034

View Report

General Warehousing And Storage Global Market Report 2025 – By Type (Bonded Warehousing, Private Warehousing and Storage, and Warehousing (including foreign trade zones)), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By End User (Manufacturing, Consumer Goods, Retail, Food and Beverages, IT Hardware, Healthcare, Chemicals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Refrigerated Warehousing And Storage Global Market Report 2025 – By Type (Cold Storage, Frozen Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By Application (Fruits & Vegetables, Bakery & Confectionery, Milk & Dairy Products, Meat, Seafood, Beverages, Other Applications)– Market Size, Trends, And Global Forecast 2025-2034

View Report

Specialized Warehousing And Storage Global Market Report 2025 – By Type (Automobile Dead Storage, Bulk Petroleum And Chemical Storage, Document Storage And Warehousing, Whiskey Warehousing, Other Specialized Warehousing And Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By End-Use (Retail Industry, Manufacturing Industry, Consumer Goods Industry, Food & Beverage Industry, Healthcare Industry, Other End Users)– Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Viral Gastroenteritis market?

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever. For further insights on the Viral Gastroenteritis market, request a sample here

How will the Viral Gastroenteritis market drivers and restraints affect the market dynamics? What forces will shape the Viral Gastroenteritis industry going forward?

The Viral Gastroenteritis market major growth driver - Rising Prevalence Of Gastrointestinal Disorders To Drive Market Growth. For further insights on the Viral Gastroenteritis market, request a sample here

What is the forecast market size or the forecast market value of the Viral Gastroenteritis market?

The Viral Gastroenteritis market size has grown strongly in recent years. The viral gastroenteritis market size has grown steadily in recent years. It will grow from $6.75 billion in 2024 to $7.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to the prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, and climate and environmental factors The viral gastroenteritis market size is expected to see strong growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to global health preparedness, climate change impact, one health approach, epidemiological surveillance systems, education and public awareness. Major trends in the forecast period include vaccine development, advanced diagnostics, telemedicine in diagnosis, collaborative research initiatives, personalized medicine approaches, and digital health solutions. For further insights on the Viral Gastroenteritis market, request a sample here

How is the Viral Gastroenteritis market segmented?

The viral gastroenteritis market covered in this report is segmented –
1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics For further insights on the Viral Gastroenteritis market, request a sample here

Which region has the largest share of the Viral Gastroenteritis market? What are the other regions covered in the report?

North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Viral Gastroenteritis market, request a sample here.

Who are the major players in the Viral Gastroenteritis market?

Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited . For further insights on the Viral Gastroenteritis market, request a sample here.

What are the key trends in the Viral Gastroenteritis market?

Major trends in the Viral Gastroenteritis market include Product Innovations Transforming The Viral Gastroenteritis Market. For further insights on the Viral Gastroenteritis market, request a sample here.

What are the major opportunities in the Viral Gastroenteritis market? What are the strategies for the Viral Gastroenteritis market?

For detailed insights on the major opportunities and strategies in the Viral Gastroenteritis market, request a sample here.

How does the Viral Gastroenteritis market relate to the overall economy and other similar markets?

For detailed insights on Viral Gastroenteritis's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Viral Gastroenteritis industry?

For detailed insights on the mergers and acquisitions in the Viral Gastroenteritis industry, request a sample here.

What are the key dynamics influencing the Viral Gastroenteritis market growth? SWOT analysis of the Viral Gastroenteritis market.

For detailed insights on the key dynamics influencing the Viral Gastroenteritis market growth and SWOT analysis of the Viral Gastroenteritis industry, request a sample here.